Capital Advisory Group Advisory Services’s Idexx Laboratories IDXX Stock Holding History

Capital Advisory Group Advisory Services’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-400	Closed	-$219K	–	328
2022 Q1	$219K	Sell	400 -12	-3%	-$6.31K	0.1%	149
2021 Q4	$271K	Buy	412 +2	+0.5%	+$1.26K	0.12%	134
2021 Q3	$255K	Sell	410 -40	-9%	-$26.9K	0.09%	172
2021 Q2	$284K	Sell	450 -47	-9%	-$26K	0.1%	158
2021 Q1	$243K	Buy	497 +11	+2%	+$5.51K	0.09%	164
2020 Q4	$243K	Sell	486 -29	-6%	-$13K	0.1%	155
2020 Q3	$202K	Hold	515	–	–	0.1%	132
2020 Q2	$170K	Buy	515 +487	+1,739%	+$141K	0.1%	147
2020 Q1	$7K	Buy	+28	New	+$7.31K	0.01%	272

Other funds holding IDXX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Capital Advisory Group Advisory Services's IDXX Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Idexx Laboratories (IDXX) in Q2 2022, closing a stake of 400 shares — an estimated $219K sold.

Capital Advisory Group Advisory Services first reported a position in IDXX in Q1 2020 and held it in 9 quarters. The position peaked at $284K in Q2 2021. 956 funds tracked by Wall St. Rank hold IDXX as of Q2 2022.

Capital Advisory Group Advisory Services reported no remaining Idexx Laboratories position as of Q2 2022 after selling out during the quarter.
Capital Advisory Group Advisory Services sold 400 Idexx Laboratories shares in Q2 2022, an estimated $219K.
Capital Advisory Group Advisory Services first reported a position in Idexx Laboratories in Q1 2020 and held it in 9 quarters.
Capital Advisory Group Advisory Services's Idexx Laboratories position peaked at $284K in Q2 2021.
956 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.